Eli Lilly & Co
- SEC CIK
- 0000059478
No open-market purchases or sales filed in the past year.
Current role at each company
- SGTX Sigilon Therapeutics, Inc.10% Owneras of Aug 14, 2023
- AKUS Akouos, Inc.10% Owneras of Dec 1, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Eli Lilly & Co as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SGTX Sigilon Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2023 (view filing)4:30 PM ET | Aug 11 | 3 days | Eli Lilly & Co and 1 other10% Owner | PPurchase | +1.72M | $14.92 | +$25.6M | New position100 after |
AKUS Akouos, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 (view filing)4:10 PM ET | Nov 30 | 1 day | Eli Lilly & Co and 1 other10% Owner | PPurchase | +30.0M | $12.50 | +$374.9M | New position100 after |